 Effect zidovudine Pneumocystis pneumonia prophylaxis progression infection AIDS Multicenter AIDS Cohort Study effectiveness zidovudine therapy primary prophylaxis Pneumocystis carinii pneumonia PCP individuals large cohort observational study October October cohort men study Markov chain transitional analysis effect zidovudine PCP prophylaxis probability progression infection AIDS months follow-up visits disease states states lymphocyte counts presence HIV-related symptoms Use pre-AIDS zidovudine PCP prophylaxis significant reductions rates progression AIDS months participants lymphocytes/microliter lymphocytes/microliter non-significant protective trends month intervals multivariate log-linear models treatment effect due effects zidovudine PCP prophylaxis probability progression first episode PCP month intervals study early primary PCP prophylaxis effective first episodes PCP efficacy zidovudine clinical trials population level